U
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97372711
- Registration number
- 7580622
- Mark type
- Word mark
- Filed
- 20 Apr 2022
- Published for opposition
- 21 Mar 2023
- Registered
- 26 Nov 2024
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
- Class 040 — Treatment of materials: Manufacturing services for others in the field of pharmaceutical preparations
- Class 042 — Scientific and technological services: Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in the fields of immunotherapy and oncology
- Class 044 — Medical, beauty and agricultural services: Medical consulting services in the fields of immunotherapy and oncology
Owner
- Umoja Biopharma, Inc., Seattle, WA, US
- Umoja Biopharma, Inc., Seattle, WA, US
- Umoja Biopharma, Inc., Seattle, WA, US
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Oct 2024 — USE AMENDMENT FILED
- 28 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 08 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2024 — SOU EXTENSION 2 GRANTED
- 07 May 2024 — SOU EXTENSION 2 FILED
- 07 May 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Nov 2023 — SOU EXTENSION 1 GRANTED
- 08 Nov 2023 — SOU EXTENSION 1 FILED
- 15 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL